Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Gerratana

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
The Journal of Pathology|November 3, 2020
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancerDavide Viotto, Francesca Russo, Ilaria Anania, et al.
Critical Reviews in Oncology/Hematology|June 8, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Maria Grazia Razeti, Aldo Caltavituro, et al.
The Oncologist|March 12, 2022
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design SimulationLorenzo Gerratana, Jean-Yves Pierga, James M Reuben, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled AnalysisWolfgang Janni, Thomas W P Friedl, Tracy C Yab, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Jean-Yves Pierga, James Reuben, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
The Journal of Pathology|November 3, 2020
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancerDavide Viotto, Francesca Russo, Ilaria Anania, et al.
Critical Reviews in Oncology/Hematology|June 8, 2025
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Maria Grazia Razeti, Aldo Caltavituro, et al.
The Oncologist|March 12, 2022
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design SimulationLorenzo Gerratana, Jean-Yves Pierga, James M Reuben, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled AnalysisWolfgang Janni, Thomas W P Friedl, Tracy C Yab, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Jean-Yves Pierga, James Reuben, et al.
Pageof 13